diabetes mellitus, type 2
Showing NaN - NaN of 133
Diabetes, Type 2 Trial in Worldwide (linagliptin, glimepiride, linagliptin )
Diabetes, Type 2 Trial in Berlin (Semaglutide 3 mg, Semaglutide 7 mg, Semaglutide B 3 mg)
Completed
- Diabetes Mellitus, Type 2
- Semaglutide 3 mg
- +7 more
-
Berlin, GermanyNovo Nordisk Investigational Site
Nov 13, 2019
Diabetes, Type 2 Trial in Worldwide (Glimepiride, Metformin, Pioglitazone)
Cardiovascular Disease, Diabetes, Type 2 Trial in Worldwide (Dulaglutide, Placebo)
Completed
- Cardiovascular Disease
- Diabetes Mellitus, Type 2
- Dulaglutide
- Placebo
-
Mobile, Alabama
- +300 more
Sep 18, 2019
Diabetes, Type 2 Trial in Worldwide (Human Insulin Inhalation Powder, Insulin Glargine)
Completed
- Diabetes Mellitus, Type 2
- Human Insulin Inhalation Powder
- Insulin Glargine
-
Fresno, California
- +68 more
Sep 6, 2019
Diabetes, Type 2 Trial in Worldwide (Human Insulin Inhalation Powder, Injectable insulin)
Completed
- Diabetes Mellitus, Type 2
- Human Insulin Inhalation Powder
- Injectable insulin
-
Sacramento, California
- +42 more
Sep 6, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- placebo
-
Alabaster, Alabama
- +427 more
Jul 3, 2019
Diabetes, Diabetes, Type 2 Trial in Berlin (Semaglutide, Probenecid, Ciclosporin)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- Semaglutide
- +2 more
-
Berlin, GermanyNovo Nordisk Investigational Site
Jun 18, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- insulin glargine
-
Birmingham, Alabama
- +230 more
May 28, 2019
Diabetes, Diabetes, Type 2, Healthy Trial in Berlin (semaglutide, )
Completed
- Diabetes
- +2 more
- semaglutide
- placebo
-
Berlin, GermanyNovo Nordisk Investigational Site
Jan 2, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, liraglutide, exenatide)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec/liraglutide
- +2 more
-
Birmingham, Alabama
- +108 more
Dec 7, 2018
Diabetes, Type 2, Cardiovascular Diseases, Risk Factors Trial in Worldwide (Placebo, Canagliflozin (JNJ-28431754) 100 mg,
Completed
- Diabetes Mellitus, Type 2
- +2 more
- Placebo
- +2 more
-
Birmingham, Alabama
- +312 more
Nov 5, 2018
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, sitagliptin, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- +2 more
-
Phoenix, Arizona
- +105 more
Sep 3, 2018
Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in Berlin (NNC9204-1513, Glucagon, Placebo)
Completed
- Diabetes
- +2 more
- NNC9204-1513
- +2 more
-
Berlin, GermanyNovo Nordisk Investigational Site
Sep 3, 2018
Diabetes, Diabetes, Type 2 Trial in United States (rosiglitazone, inhaled human insulin, metformin)
Terminated
- Diabetes
- Diabetes Mellitus, Type 2
- rosiglitazone
- +3 more
-
Hueytown, Alabama
- +102 more
Sep 3, 2018
Diabetes, Type 2 Trial in Worldwide (, linagliptin)
Diabetes, Type 2 Trial in Worldwide (LY2605541, Insulin Glargine, Insulin Lispro)
Type 2 Diabetes, Diabetes, Type 2 Trial in United States (Biphasic Remogliflozin Etabonate, Placebo)
Completed
- Type 2 Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Biphasic Remogliflozin Etabonate
- Placebo
-
Tucson, Arizona
- +18 more
Jan 16, 2018
Diabetes, Type 2 Trial in Worldwide (GSK189075, pioglitazone, Placebo)
Diabetes, Type 2 Trial in Worldwide (GSK189075, Placebo)
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, , liraglutide)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec
- +2 more
-
Anaheim, California
- +131 more
Aug 25, 2017
Diabetes, Diabetes, Type 2 Trial in Austria, Germany, Switzerland (insulin detemir, insulin aspart, biphasic insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin detemir
- +2 more
-
Graz, Austria
- +126 more
Jun 26, 2017